等待開盤 09-20 09:30:00 美东时间
0.000
0.00%
Replimune Group (NASDAQ:REPL) said on Thursday it entered into a securities purchase agreement for a private investment in public equity ("PIPE"). The biotechnology company will issue and sell 5,668,9...
06-13 21:47
U.S. stocks traded mixed toward the end of trading, with the S&P 500 fallin...
06-07 02:45
U.S. stocks traded mixed midway through trading, with the Dow Jones index gaini...
06-07 00:22
Replimune Group (NASDAQ:REPL) said that topline results of an analysis of a trial of RP1 plus Bristol-Myers Squibb's (BMY) Opdivo (nivolumab) in melanoma patients who failed on a PD-1 inhibitor indica...
06-07 00:05
An update from Replimune Group (REPL) is now available. Replimune Group, Inc. h...
06-06 22:03
U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite trading higher on Tuesday. The Dow traded down 0.18% to 36,138.19 while the NASDAQ rose 0.19% to 14,212.19. The S&P 500 also fell, dropping, 0.07% to 4,566.73.
2023-12-06 03:27
Shares of Daktronics, Inc. (NASDAQ: DAKT) moved lower during Tuesday’s session following weak quarterly results.
2023-12-06 02:06
U.S. stocks traded mixed midway through trading, with the Dow Jones index falling around 100 points on Tuesday. The Dow traded down 0.28% to 36,103.52 while the NASDAQ rose 0.32% to 14,230.64. The S&P 500 also fell, dropping, 0.03% to 4,568.46.
2023-12-06 01:11
U.S. stocks traded lower this morning, with the Nasdaq Composite falling over 50 points on Tuesday. Following the market opening Tuesday, the Dow traded down 0.23% to 36,120.88 while the NASDAQ fell 0.40% to 14,129.09. The S&P 500 also fell, dropping, 0.30% to 4,556.06.
2023-12-05 22:39
Replimune Group Inc (NASDAQ: REPL) announced results from the primary analysis of the CERPASS trial evaluating RP1 in combination with cemiplimab for locally advanced or metastatic cutaneous
2023-12-05 21:49